← Back to Search

Procedure

Dry Needling for Scars

N/A

Recruiting

Research Sponsored by Iran University of Medical Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 20 and 60 years

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change in pain after the end of 6 treatment sessions compared to baseline and change from baseline at 2-week follow up

Awards & highlights

Study Summary

This trial seeks to understand if dry needling can help people with scar tissue, which can limit joint mobility and affect daily activities.

Who is the study for?

This trial is for individuals aged 20-60 with linear hypertrophic scars older than six weeks, without joint movement restrictions near the scar. It's not suitable for those with a fear of needles, diabetes, keloid scars, skin infections near the scar tissue, altered joint mobility due to fractures or those on anticoagulant medications.Check my eligibility

What is being tested?

The study tests dry needling's effectiveness on improving flexibility and reducing complications from surgery or trauma-induced linear hypertrophic scars. Participants will receive either true dry needling or sham (fake) treatment to compare outcomes.See study design

What are the potential side effects?

Dry needling may cause discomfort at the needle site, minor bleeding or bruising, temporary soreness in the treated area and less commonly can lead to fatigue after treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 20 and 60 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change in health status after the end of 6 treatment sessions compared to baseline and change from baseline at 2-week follow up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change in health status after the end of 6 treatment sessions compared to baseline and change from baseline at 2-week follow up

This trial's timeline: 3 weeks for screening, Varies for treatment, and change in health status after the end of 6 treatment sessions compared to baseline and change from baseline at 2-week follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Flexibility of the scar tissue (tissue compliance)

Secondary outcome measures

Active and passive joint range of motion

Health-related quality of life

Pain intensity

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: True dry needling of the hypertrophic scar tissueExperimental Treatment1 Intervention

Participants with hypertrophic linear scar tissue in the true dry needling group will undergo authentic dry needling interventions targeted at the scar tissue, in conjunction with routine physiotherapy.

Group II: Sham dry needling of the hypertrophic scar tissuePlacebo Group1 Intervention

In the sham dry needling group, participants presenting with hypertrophic linear scar tissue will receive superficial dry needling of the skin, performed at a location distinct from the scar tissue. This will be administered alongside routine physiotherapy.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Iran University of Medical SciencesLead Sponsor

26 Previous Clinical Trials

1,889 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical investigation accept participants over the age of 65?

"According to the inclusion criteria, this research is only available for people aged between 20 and 60. Meanwhile, there are 24 trials tailored specifically to teenagers and 98 more designed for elderly patients over 65 years old."

Answered by AI

Is participation in this clinical experiment open to the public?

"Candidates who have hypertrophic scarring and are between the ages of 20-60 may be accepted to this clinical trial. Approximately 80 participants will be enrolled in total."

Answered by AI

Is it possible to sign up for the clinical trial at this time?

"As displayed on clinicaltrials.gov, this particular medical study is no longer actively recruiting for participants - the initial posting was October 10th 2023 and it has since been updated as of September 5th 2023. However, there are still 126 other trials that require patients at this point in time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effectiveness of Dry Needling in Linear Scar Tissue

2023. "Effectiveness of Dry Needling in Linear Scar Tissue". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06033430.

All > Hypertrophy